The current performance-linked and risk sharing agreement scene in the Spanish region of Catalonia

Abstract

Traditional drug payment schemes in Catalonia are generally based on the negotiation of fixed prices; however, disadvantages arise in the case of innovative therapies. Risk sharing agreements distribute potential health and economic uncertainties and high prices on access across the interested parts. (...)